首页> 外文期刊>Journal of Molecular Biology >Poloxamer 188 copolymer membrane sealant rescues toxicity of amyloid oligomers in vitro.
【24h】

Poloxamer 188 copolymer membrane sealant rescues toxicity of amyloid oligomers in vitro.

机译:Poloxamer 188共聚物膜密封剂可在体外挽救淀粉样低聚物的毒性。

获取原文
获取原文并翻译 | 示例
           

摘要

Amyloid oligomers and protofibrils increase cell membrane permeability, eventually leading to cell death. Here, we demonstrate that amyloid oligomer toxicity and membrane permeabilization can be reversed using the membrane sealant copolymer poloxamer 188. The data indicate that amyloid oligomer toxicity is caused by defects in the lipid bilayer of the type that are sealed by poloxamer 188. Our results also suggest the possibility of using polymer-based membrane sealants to prevent or reverse amyloid oligomer toxicity in vivo. Because the ability to permeabilize membranes is a generic property of amyloid oligomers, this therapeutic approach may be effective for the treatment of many degenerative diseases caused in part by the interaction of misfolded proteins with cell membranes, as in Alzheimer's disease, type II diabetes, and a host of others.
机译:淀粉样蛋白低聚物和原纤维增加细胞膜通透性,最终导致细胞死亡。在这里,我们证明了使用膜密封剂共聚物泊洛沙姆188可逆转淀粉样蛋白低聚物的毒性和膜通透性。数据表明,淀粉样蛋白低聚物的毒性是由泊洛沙姆188密封的脂质双层类型的缺陷引起的。我们的结果也提示使用基于聚合物的膜密封剂在体内预防或逆转淀粉样蛋白低聚物毒性的可能性。由于透化膜的能力是淀粉样蛋白低聚物的普遍特性,因此这种治疗方法可能有效治疗部分由错误折叠的蛋白质与细胞膜相互作用引起的许多变性疾病,例如阿尔茨海默氏病,II型糖尿病和许多其他人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号